Vincent Vultaggio
Pao And Pfo at Zentalis Pharmaceuticals, Inc. (ZNTL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $105K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 10SEC | ZNTLZentalis Pharmaceuticals, Inc. | Sell Plan | 29,951156,779 held (−16%) | $2.43 | $73K | +8.6% |
| Feb 10SEC | ZNTLZentalis Pharmaceuticals, Inc. | Sell Plan | 3,379153,400 held (−2%) | $2.39 | $8K | +10.5% |
| Feb 10SEC | ZNTLZentalis Pharmaceuticals, Inc. | Sell Plan | 6,894146,506 held (−4%) | $2.42 | $17K | +9.1% |
| Feb 4SEC | ZNTLZentalis Pharmaceuticals, Inc. | Sell Plan | 2,540187,286 held (−1%) | $2.55 | $6K | +3.5% |
| Feb 4SEC | ZNTLZentalis Pharmaceuticals, Inc. | Sell Plan | 556186,730 held (−0%) | $2.52 | $1K | +4.8% |
- Sell
Pao And Pfo Vincent Vultaggio sold $73K of ZNTL at $2.43 — pre-scheduled 10b5-1 plan sale.
- Sell
Pao And Pfo Vincent Vultaggio sold $8K of ZNTL at $2.39 — pre-scheduled 10b5-1 plan sale.
- Sell
Pao And Pfo Vincent Vultaggio sold $17K of ZNTL at $2.42 — pre-scheduled 10b5-1 plan sale.
- Sell
Pao And Pfo Vincent Vultaggio sold $6K of ZNTL at $2.55 — pre-scheduled 10b5-1 plan sale.
- Sell
Pao And Pfo Vincent Vultaggio sold $1K of ZNTL at $2.52 — pre-scheduled 10b5-1 plan sale.